Nautilus Biotechnology, Inc. - Common Stock (NAUT)
Competitors to Nautilus Biotechnology, Inc. - Common Stock (NAUT)
10x Genomics TXG -5.27%
10x Genomics is a leader in genomic analysis technology, especially in single-cell and spatial transcriptomics. Their sophisticated platforms for understanding complex biological systems put them in direct competition with Nautilus, which operates in protein analysis. 10x Genomics’ robust data generation capabilities and established market presence give them a competitive edge over Nautilus, as they continue to innovate and expand their technological offerings.
Agilent Technologies A -6.08%
Agilent Technologies competes with Nautilus Biotechnology primarily through its diverse offerings in the life sciences and chemical analysis sectors, including advanced liquid chromatography and mass spectrometry tools. Both companies aim to improve proteomic analysis methodologies, but Agilent's established reputation and broad suite of products give them a notable advantage in overcoming customer hesitations regarding technology adoption and integration.
Bruker Corporation BRKR -3.72%
Bruker Corporation specializes in high-performance scientific instruments and analytical solutions for life science applications, making it a direct competitor to Nautilus in the protein analysis segment. With a focus on providing cutting-edge mass spectrometry and NMR solutions, Bruker has a well-respected brand and extensive experience in the market, allowing them to provide comprehensive solutions that may outpace Nautilus's offerings.
LC Sciences
LC Sciences focuses on providing custom microarray services and genomic analysis, emphasizing its expertise in advanced bioinformatics and nanotechnology. This positions them in direct competition with Nautilus Biotechnology in the proteomics space, particularly as Nautilus aims to revolutionize protein analysis and characterization. LC Sciences’ established technology and experience in high-throughput assays present significant competition for Nautilus as they seek to gain market share in the protein analysis domain.
Thermo Fisher Scientific TMO -6.83%
Thermo Fisher Scientific is a global leader in laboratory equipment and supplies, including mass spectrometry and proteomics tools. They pose a significant competitive challenge for Nautilus Biotechnology, which specializes in protein analysis technology. Thermo Fisher's extensive product portfolio, established customer base, and strong R&D capabilities offer them a distinctly favorable position in the market, allowing them to provide integrated solutions that Nautilus must strive to meet.